Table 4.
Performance Measure | Age Group
|
p-value for trend | ||||
---|---|---|---|---|---|---|
65–69 | 70–74 aOR* (95% CI) |
75–79 aOR (95% CI) |
80–84 aOR (95% CI) |
85+ aOR (95% CI) |
||
Recall Rate | Referent | 0.96 (0.92, 1.01) | 0.93 (0.88, 0.99) | 0.86 (0.80, 0.92) | 0.79 (0.71, 0.89) | <0.001 |
Sensitivity | Referent | 1.02 (0.60, 1.71) | 0.79 (0.48, 1.31) | 0.69 (0.39, 1.23) | 0.84 (0.42, 1.65) | 0.17 |
Specificity | Referent | 1.06 (1.01, 1.11) | 1.09 (1.03, 1.16) | 1.18 (1.10, 1.27) | 1.34 (1.19, 1.50) | <0.001 |
PPV1** | Referent | 1.24 (1.06, 1.45) | 1.33 (1.13, 1.56) | 1.25 (0.99, 1.56) | 1.91 (1.45, 2.51) | <0.001 |
CDR*** | Referent | 1.18 (1.02, 1.37) | 1.21 (1.04, 1.40) | 1.07 (0.86, 1.33) | 1.46 (1.13, 1.90) | 0.01 |
aOR = odds ratio adjusted for registry site, race/ethnicity, family history of breast cancer, breast density, history of breast procedure, current hormone therapy use, time since previous mammogram, and examination year.
PPV1 = Positive predictive value
CDR = cancer detection rate per 1000 examinations